Impacting society, creating change
Technologies developed at Ohio State are changing the world. Learn more about the startups that are currently a part of the Ohio State portfolio or download our printable catalog (as of June 30, 2019).
Search for a Startup below
Engage Health’s primary care skin cancer diagnostic tool is based on infrared optics technology developed at Ohio State and the James Cancer Hospital. The diagnostic tool is non-invasive, quick operating, and easy to use. As a result, this diagnostic tool accomplishes the following: increases referral effectiveness by doctors, generates revenue for primary care facilities, and reduces patient anxiety by eliminating both the diagnosis waiting times and lengthy referral process.
Eikonoklastes Therapeutics is a preclinical stage biopharmaceutical company developing a novel immunotherapy based on Ohio State research to treat several diseases with significant unmet clinical need. Triple-Negative Breast Cancer (TNBC), is a devastating subtype in urgent need of a novel therapy, is the lead indication. Breast cancer is the most common newly diagnosed cancer and the second leading cause of death among women in the United States. Breast cancer deaths are largely the result of recurrent and metastatic disease that typically does not respond well to current treatments.
CoreAccess offers a mobile application hub for healthcare providers, including physicians and trainees, to navigate their hospital systems as they learn, plan and provide care. Based on technology built at Ohio State and developed by resident physicians in the field, CoreAccess delivers a centralized application integrated with hospital systems, combining educational materials and clinical guidelines with scheduling and communication tools to improve workflow and streamline patient care.
Provides radiation biodosimetry technology intended for a minimally invasive rapid-response testing kit for an emergency. The company technology is used to assess biological exposure to radiation to enhance patient care and can also be used to assess exposure via a rapid, affordable, highly-sensitive, simple blood test that dictates care plans for emergency response in event of accidental radiation exposure.